Copy number variations identified in thyroid FNA specimens are associated with Hurthle cell cytomorphology

被引:8
作者
Abi-Raad, Rita [1 ]
Prasad, Manju L. [1 ]
Adeniran, Adebowale J. [1 ]
Cai, Guoping [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
copy number variations; fine-needle aspiration; Hurthle cell features; Hurthle cell neoplasm; thyroid; FINE-NEEDLE-ASPIRATION; CHROMOSOMAL-ABERRATIONS; CANCER-DIAGNOSIS; LESIONS; CARCINOMA; NODULES; BENIGN; TUMORS; PERFORMANCE; CLASSIFIER;
D O I
10.1002/cncy.22569
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The fine-needle aspiration (FNA) diagnosis of thyroid Hurthle cell neoplasms (HCNs) remains challenging. This study explored a possible association of copy number variations (CNVs) with Hurthle cell lesions of the thyroid. Methods Thyroid FNA cases that were diagnosed as follicular lesion of undetermined significance (FLUS) or follicular neoplasm (FN)/HCN for which the ThyroSeq version 3 genomic classifier test was performed were retrieved. Results A total of 324 thyroid FNA cases (228 FLUS cases, 46 HCN cases, and 50 FN cases) were included in the study. FLUS cases were further classified as Hurthle cell type (follicular lesion of undetermined significance-Hurthle cell type [FLUS-HCT]; 20 cases) or non-Hurthle cell type (follicular lesion of undetermined significance-non-Hurthle cell type [FLUS-NHCT]; 208 cases). HCN and FLUS-HCT cases showed a higher prevalence of CNVs (23 of 66 [35%]) in comparison with those classified as FN or FLUS-NHCT (14 of 258 [5%]; P < .001). A total of 105 patients had histopathologic follow-up. Cases with CNVs were more likely to be neoplastic (18 of 26 [69%]) and associated with Hurthle cell changes (14 of 26 [54%]) in comparison with cases without any molecular alterations (neoplastic, 8 of 24 [33%]; Hurthle cell changes, 2 of 24 [8%]; P < .05). In HCN/FLUS-HCT cases with CNVs (n = 14), Hurthle cell changes (13 of 14 [93%]) and neoplasms (9 of 14 [64%]) were more likely to be seen on surgical follow-up in comparison with the 17 cases without CNVs (Hurthle cell changes, 6 of 17 [35%]; neoplastic, 3 of 17 [18%]; P < .05). Conclusions CNVs identified in thyroid FNA cases are associated with Hurthle cell morphology and are suggestive of a neoplasm with Hurthle cell features in thyroid FNAs classified as FLUS-HCT/HCN. This finding may be helpful in triaging patients who would benefit from surgical management.
引用
收藏
页码:415 / 422
页数:8
相关论文
共 36 条
  • [1] Integrated Genomic Characterization of Papillary Thyroid Carcinoma
    Agrawal, Nishant
    Akbani, Rehan
    Aksoy, B. Arman
    Ally, Adrian
    Arachchi, Harindra
    Asa, Sylvia L.
    Auman, J. Todd
    Balasundaram, Miruna
    Balu, Saianand
    Baylin, Stephen B.
    Behera, Madhusmita
    Bernard, Brady
    Beroukhim, Rameen
    Bishop, Justin A.
    Black, Aaron D.
    Bodenheimer, Tom
    Boice, Lori
    Bootwalla, Moiz S.
    Bowen, Jay
    Bowlby, Reanne
    Bristow, Christopher A.
    Brookens, Robin
    Brooks, Denise
    Bryant, Robert
    Buda, Elizabeth
    Butterfield, Yaron S. N.
    Carling, Tobias
    Carlsen, Rebecca
    Carter, Scott L.
    Carty, Sally E.
    Chan, Timothy A.
    Chen, Amy Y.
    Cherniack, Andrew D.
    Cheung, Dorothy
    Chin, Lynda
    Cho, Juok
    Chu, Andy
    Chuah, Eric
    Cibulskis, Kristian
    Ciriello, Giovanni
    Clarke, Amanda
    Clayman, Gary L.
    Cope, Leslie
    Copland, John A.
    Covington, Kyle
    Danilova, Ludmila
    Davidsen, Tanja
    Demchok, John A.
    DiCara, Daniel
    Dhalla, Noreen
    [J]. CELL, 2014, 159 (03) : 676 - 690
  • [2] Do benign thyroid nodules have malignant potential? An evidence-based review
    Arora, Nimmi
    Scognamiglio, Theresa
    Zhu, Baixin
    Fahey, Thomas J., III
    [J]. WORLD JOURNAL OF SURGERY, 2008, 32 (07) : 1237 - 1246
  • [3] Performance of the Afirma Gene Expression Classifier in Hurthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules
    Brauner, Eran
    Holmes, Brittany J.
    Krane, Jeffrey F.
    Nishino, Michiya
    Zurakowski, David
    Hennessey, James V.
    Faquin, William C.
    Parangi, Sareh
    [J]. THYROID, 2015, 25 (07) : 789 - 796
  • [4] BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization
    Ciampi, R
    Zhu, ZW
    Nikiforov, YE
    [J]. ENDOCRINE PATHOLOGY, 2005, 16 (02) : 99 - 105
  • [5] The Bethesda System for Reporting Thyroid Cytopathology
    Cibas, Edmund S.
    Ali, Syed Z.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 658 - 665
  • [6] Genome Haploidisation with Chromosome 7 Retention in Oncocytic Follicular Thyroid Carcinoma
    Corver, Willem E.
    Ruano, Dina
    Weijers, Karin
    den Hartog, Wietske C. E.
    van Nieuwenhuizen, Merlijn P.
    de Miranda, Noel
    van Eijk, Ronald
    Middeldorp, Anneke
    Jordanova, Ekaterina S.
    Oosting, Jan
    Kapiteijn, Ellen
    Hovens, Guido
    Smit, Jan
    van Wezel, Tom
    Morreau, Hans
    [J]. PLOS ONE, 2012, 7 (06):
  • [7] The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
    Davis, Caleb F.
    Ricketts, Christopher J.
    Wang, Min
    Yang, Lixing
    Cherniack, Andrew D.
    Shen, Hui
    Buhay, Christian
    Kang, Hyojin
    Kim, Sang Cheol
    Fahey, Catherine C.
    Hacker, Kathryn E.
    Bhanot, Gyan
    Gordenin, Dmitry A.
    Chu, Andy
    Gunaratne, Preethi H.
    Biehl, Michael
    Seth, Sahil
    Kaipparettu, Benny A.
    Bristow, Christopher A.
    Donehower, Lawrence A.
    Wallen, Eric M.
    Smith, Angela B.
    Tickoo, Satish K.
    Tamboli, Pheroze
    Reuter, Victor
    Schmidt, Laura S.
    Hsieh, James J.
    Choueiri, Toni K.
    Hakimi, A. Ari
    Chin, Lynda
    Meyerson, Matthew
    Kucherlapati, Raju
    Park, Woong-Yang
    Robertson, A. Gordon
    Laird, Peter W.
    Henske, Elizabeth P.
    Kwiatkowski, David J.
    Park, Peter J.
    Morgan, Margaret
    Shuch, Brian
    Muzny, Donna
    Wheeler, David A.
    Linehan, W. Marston
    Gibbs, Richard A.
    Rathmell, W. Kimryn
    Creighton, Chad J.
    Signoretti, Sabina
    Seiler, Michael
    Chao, Hsu
    Dahdouli, Mike
    [J]. CANCER CELL, 2014, 26 (03) : 319 - 330
  • [8] Molecular alterations in Hurthle cell nodules and preoperative cancer risk
    Doerfler, William R.
    Nikitski, Alyaksandr, V
    Morariu, Elena M.
    Ohori, N. Paul
    Chiosea, Simion, I
    Landau, Michael S.
    Nikiforova, Marina N.
    Nikiforov, Yuri E.
    Yip, Linwah
    Manroa, Pooja
    [J]. ENDOCRINE-RELATED CANCER, 2021, 28 (05) : 301 - 309
  • [9] Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland - A cytomorphologic study of 139 cases with statistical analysis
    Elliott, DD
    Pitman, MB
    Bloom, L
    Faquin, WC
    [J]. CANCER CYTOPATHOLOGY, 2006, 108 (02) : 102 - 109
  • [10] Frisk T, 1999, GENE CHROMOSOME CANC, V25, P349, DOI 10.1002/(SICI)1098-2264(199908)25:4<349::AID-GCC6>3.3.CO